Executive readout · one minute
Call research workspace
Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.
TMDX
$88.58
-1.18%
TMDX · TransMedics Group, Inc.
$88.58
-1.06 (-1.18%)
At close · Aug 14
Market Cap
$3.07B
Shares
34.68M
All earnings calls
Earnings call · FY2026 Q2
TransMedics Group, Inc. Q2 FY2026 Earnings Call
TransMedics Group, Inc. Q2 FY2026 Earnings Call
Forward guidance
1 guided metrics
Management's latest ranges and targets are included below.
Research coverage
2 live sources
Switch sources without leaving this page or losing your listening position.
Revenue
$189.95M
+20.7% YoY
Diluted EPS
$0.41
-55.4% YoY
Gross margin
59.6%
-1.8 pp YoY
Net income
$14.68M
-57.9% YoY
Research materials
Open the source you need; every reader stays inside this workspace.
Forward guidance
From the 8-K filed Aug 4, 2026.
| Metric | Period | Guided | Basis |
|---|---|---|---|
|
Total revenue
full-year 2026
|
$737M – $757M | — |
Quarter detail
How the reported period landed and where the business moved.
SEC filing · Item 2.02
8-K earnings release
Filed Aug 4, 2026 · complete as-filed document
SEC periodic report
10-Q report
Filed Aug 4, 2026 · complete as-filed document